Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
6 The Company Das Unternehmen<br />
The <strong>biolitec</strong> Group<br />
<strong>biolitec</strong> is the technology leader in diode lasers, fiber optic disposables and photodynamic drugs. The<br />
company is the only supplier for photodynamic therapy worldwide that offers all relevant core competencies<br />
– photosensitizers, lasers and optical fibers as well as an approved cancer drug (Foscan®) including<br />
the active substance Temoporfin®. The combination of medical technology and drug development<br />
for diverse medical indications is an outstanding feature of <strong>biolitec</strong>. Lasers and the pertinent disposables<br />
represent the medtech area responsible for <strong>biolitec</strong>s profitability and dynamic growth opportunities.<br />
Temoporfin® as an active substance and Foscan® as a drug represent the biotech area and a further<br />
future upside potential.<br />
<strong>biolitec</strong> is globally present in all relevant core markets with its broad range of lasers and fiber optic<br />
products.<br />
The current growth and innovation emphasis of <strong>biolitec</strong> is on minimally invasive therapies (BPH treatment,<br />
hemorrhoids) and aesthetics (ELVeS, laser liposuction) with a strong focus on re-establishing the<br />
patients’ quality of life.
Change language